BTA stat® test is a rapid, qualitative immunoassay (specifically, an immunochromatographic assay) that uses monoclonal antibodies to detect bladder tumor associated antigen (a human complement factor H-related protein, CFHrp) in urine, helping to qualitatively diagnose and monitor bladder cancer.